Thrombolytics, intravenous or catheter-directed, can be an effective treatment option for acute pulmonary embolism (PE) but pose a hazard to the many patients who have risk factors for serious ...

The first patient has been treated with InterVene’s Recana thrombectomy system for restoring patency (blood flow) in chronically obstructed deep veins and venous stents. The US-based clinical stage ...

Late-breaking data from the ENGULF trial showed that a novel dual-action thrombectomy device was effective and safe in treating acute pulmonary embolism (PE). The safety and effectiveness results were ...

Penumbra, Inc. announced the initiation of its FORWARD study, which will collect safety and efficacy data on mechanical ...

Thunderbolt, a computer-assisted thrombectomy device meant to address large vessel occlusions in patients with acute ischemic ...

Please provide your email address to receive an email when new articles are posted on . The FDA has granted 510(k) clearance to a Bay Area commercial stage medical technology company for its novel ...

The US Food and Drug Administration (FDA) has approved the Aspire MAX 7–11F mechanical thrombectomy system to remove blood clots from peripheral vessels, Control Medical Technology, the company that ...

CAMPBELL, Calif.--(BUSINESS WIRE)--Imperative Care, Inc. today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s Zoom System, making it the first ...

Powerfully simple thrombectomy solution provides physicians with an all-in-one, single-use aspiration catheter and pump system Intuitive design eliminates the need for capital equipment, with easy ...

Catheter used to treat deep vein thrombosis to be commercialized in U.S. and Europe MARLBOROUGH, Mass., Boston Scientific has received United States (U.S.) Food and Drug Administration (FDA) approval ...

Penumbra expands clinical research through the FORWARD stroke study while remaining part of the NYSE Composite with advanced ...